Skip to main navigation
menu

Aclaris - Corp Menu

  • About Us »
    « Back
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Corporate Compliance
    • Contact
  • Research »
    « Back
    • Diseases and Conditions
    • Drug Development Pipeline
    • Drug Discovery
    • Clinical Trials
    • Publications
    • Investigator Initiated Studies
  • Partnerships
  • Careers
  • Citizenship »
    « Back
    • Social Responsibility
    • Scientist Development Program
    • Aclaris Support
  • Insights
  • Investors »
    « Back
    • Investor Overview
    • Stock Information
    • Press Releases
    • Events
    • Investor Presentations
    • SEC Filings
    • Corporate Governance
    • Investor FAQs
    • Email Alerts

Aclaris - Extras Menu

  • Media resources
  • Contact us

Aclaris - Corp Menu

  • About Us »
    « Back
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Corporate Compliance
    • Contact
  • Research »
    « Back
    • Diseases and Conditions
    • Drug Development Pipeline
    • Drug Discovery
    • Clinical Trials
    • Publications
    • Investigator Initiated Studies
  • Partnerships
  • Careers
  • Citizenship »
    « Back
    • Social Responsibility
    • Scientist Development Program
    • Aclaris Support
  • Insights
  • Investors »
    « Back
    • Investor Overview
    • Stock Information
    • Press Releases
    • Events
    • Investor Presentations
    • SEC Filings
    • Corporate Governance
    • Investor FAQs
    • Email Alerts

Aclaris - Investor Relations

  • Investor Overview
  • Stock Information
  • Press Releases
  • Events
  • SEC Filings
  • Corporate Governance
  • Investor Presentations
  • Investor FAQs
  • Email Alerts
Investor Contact
For investor related questions, please email
investors@aclaristx.com

Highlights

Highlights

Governance Documents
Bylaws 260.7 KB
Charter 153.6 KB
Code of Business Conduct and Ethics 366 KB
Corporate Governance Guidelines 127.1 KB
Whistleblower Policy 442.6 KB
Committee Charters
Audit Committee Charter 161.4 KB
Compensation Committee Charter 177.9 KB
Executive Compliance Committee Charter 171.7 KB
Nominating and Corporate Governance Committee Charter 35.6 KB
Research and Development Committee Charter 96.6 KB
Committee Composition
Audit Compensation Nominating and Corporate Governance Research and Development
Maxine Gowen Audit Compensation Research and Development
William Humphries Nominating and Corporate Governance
Anand Mehra Compensation Research and Development
Vincent Milano Compensation
Christopher Molineaux Nominating and Corporate Governance
Andrew Powell Audit Nominating and Corporate Governance
Bryan Reasons Audit
Andrew Schiff Compensation Research and Development
= Chairperson = Member

Aclaris - Footer Menu

  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Fraudulent Activity Notice
© 2023 Aclaris Therapeutics, Inc. All rights reserved. Unless otherwise noted, all trademarks referenced on this page are owned by Aclaris Therapeutics.